An Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During Chemotherapy for Ovarian Cancer

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 7, 2025

Primary Completion Date

July 30, 2026

Study Completion Date

July 30, 2027

Conditions
Ovary Cancer
Interventions
BIOLOGICAL

METR-NK cell(metabolic remodeling nature killer cells)

100 mL METR-NK cells were diluted in 500 mL 0.9% sodium chloride normal saline at 37℃, and the infusion volume of METR-NK cells was not less than 2×107 cells/kg for 1 day as a course of treatment, and the infusion time was maintained for 30 minutes on the 10th day before chemotherapy.

Trial Locations (1)

230001

Anhui Cancer Hospitail, Hefei

All Listed Sponsors
collaborator

Anhui Kecheng intelligent health technology Co., LTD

UNKNOWN

lead

Anhui Provincial Cancer Hospital

OTHER

NCT07096583 - An Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During Chemotherapy for Ovarian Cancer | Biotech Hunter | Biotech Hunter